DMV Angel Investing: A Guide to DC, Maryland, and Virginia Startups

The DMV produced $5.4 billion in venture funding in 2025, its second-highest year in a decade, and a string of exits most coastal angels never tracked: Mandiant to Google for $5.4 billion, Cvent to Blackstone for $4.6 billion, Tenable public on the Nasdaq. Washington DC, Maryland, and Northern Virginia make up one of the few U.S. markets where sitting next to the federal government is a structural advantage rather than a drag. This guide is part of our angel investing by region series, and it covers how the DMV actually works, who has been deploying capital, and how to get into deals whether you live in Arlington or Oakland.

Why the DMV is not like other startup markets

Most startup maps get the DMV wrong. It has none of the things people use to define a tech hub. No Sand Hill Road density. No media and finance halo. What it has instead is the largest concentration of federal contracting dollars on earth and the deepest pool of cleared technical talent in the country, both clustered in Northern Virginia. That combination produces a specific, investable archetype: the enterprise company that wins a federal beachhead, then graduates into commercial markets, or the pure cyber and govtech company that exits to a Cisco, Google, or IBM at nine and ten-figure valuations.

Virginia took in $109 billion in federal contracts in 2023, roughly 62% of it landing in Northern Virginia. That is not a side note. It is the engine. A company that survives federal procurement has passed the hardest enterprise validation there is. If you can sell to the NSA or DARPA, selling to a Fortune 100 CIO is a step down in difficulty, not up.

The federal proximity flywheel

Federal proximity works as a flywheel, not a ceiling. Government contracts function as the best enterprise customer validation available, because the procurement bar is brutally high and nearly impossible to fake. A FedRAMP authorization or a signed DoD contract is the DMV equivalent of clear product-market fit signals elsewhere. The diligence question that matters most for a DMV company is whether it has a government beachhead that proves the product without capping its commercial ceiling. Companies that get this right sell to agencies first, then expand into the much larger commercial market on the strength of that credential. Companies that get it wrong become contractors forever, dependent on the next appropriations cycle and structurally hard to exit. Telling those two apart is the core skill of investing here.

If you are still working out whether you qualify to invest in these deals at all, start with what accreditation requires and what the data shows on returns. The rest of this guide assumes you have cleared that bar.

Three sub-ecosystems, one region

The DMV runs as three loosely coupled sub-ecosystems that share talent and often exit to the same acquirers. Northern Virginia, from Arlington through Reston and Tysons, is the cyber and defense core, home to the Pentagon, major intelligence facilities, Amazon's HQ2, and the densest data-center corridor in the world. Washington DC proper runs govtech, policy-adjacent SaaS, and data intelligence, and now ranks fifth in U.S. venture ecosystem development per PitchBook despite being the 23rd-largest city. Maryland's 270 Corridor is a biotech belt anchored by the NIH, the FDA, BARDA, and Fort Detrick, with more biotech firms per capita than any county in the mid-Atlantic and roughly $2.4 billion in startup funding across 250-plus deals in 2025.

Maryland deserves its own mention because the logic is analogous but the validation source is different. Instead of a federal contract, the signal is NIH or BARDA funding, an FDA pathway, or a research partnership with Johns Hopkins. The companies look nothing alike on the surface. The underlying pattern, federal proximity as the thing that de-risks the early product, is the same.

What the DMV means

The DMV is the local shorthand for the Washington metropolitan area: the District of Columbia, the Maryland suburbs in Montgomery and Prince George's counties up through Baltimore, and the Northern Virginia counties of Arlington, Fairfax, and Loudoun. In startup terms it functions as a single market with three specialties, cyber and defense in Virginia, govtech in the District, and biotech in Maryland, connected by shared talent and a common set of acquirers.

The power-law track record

Angel returns concentrate. A small number of investments return most of the money, which is why angel returns follow a power law, and here is how many checks you need to give yourself a real shot at catching one. The DMV's exit history fits that shape cleanly. A handful of anchor outcomes define the market, and they cluster in three verticals: cybersecurity and defense, enterprise and govtech SaaS, and Maryland biotech.

Anchor exits that defined the market

The track record is not theoretical. Sourcefire, built in Columbia, Maryland, sold to Cisco for $2.7 billion in 2013. Mandiant, out of Reston, sold to Google Cloud for $5.4 billion in 2022. Cvent, from Tysons Corner, ran the full cycle, taken private by Vista for $1.65 billion in 2016, re-listed via SPAC at a $5.3 billion valuation in 2021, then bought by Blackstone for $4.6 billion in 2023. Tenable, also out of Columbia, went public on the Nasdaq in 2018. Octo, a Reston govtech firm, was acquired by IBM in 2022. AOL was built in Dulles and became the foundation of Steve Case's entire DMV investing legacy. Capital One has been compounding out of McLean since its 1994 IPO.

Two cautions keep this honest. CrowdStrike is often claimed for the DMV, but George Kurtz and Dmitri Alperovitch founded it in Irvine, California, in 2011. The connection here is real but runs through intelligence-community relationships and background, not founding geography. And the Maryland biotech names cut both ways. Novavax landed up to $1.6 billion through Operation Warp Speed but stumbled badly on COVID-era manufacturing. Emergent BioSolutions grew into a multibillion-dollar biodefense company on BARDA contracts, then hit serious quality and contamination problems in 2020 through 2022. These are real anchors with real scars. Treating them as clean success stories would be a mistake.

The Booz Allen and IC spinout engine

Here is the feature with no peer in any other market. Federal contractors and intelligence-community organizations spin out commercial technology companies at a steady clip, staffed by founders who leave with security clearances and government rolodexes intact. Booz Allen alone has produced Modzy and SnapAttack, the latter a cyber threat-hunting company that Cisco acquired in 2025, plus a long tail of informal spinouts as cleared employees walk out the door to build. Cleared founders are a distinct talent class, and they feed the region's deal flow in a way that Stanford dropouts feed the Valley's.

In-Q-Tel, the CIA's venture arm in Arlington, passed its 800th investment in April 2025. It is not an access ramp for individual angels and never will be, so do not treat it as a co-investment vehicle. Treat it as a signal. An In-Q-Tel investment in a security or dual-use company has historically been a leading indicator of federal contract wins, and Big Tech has repeatedly acquired companies out of its portfolio. Watching what In-Q-Tel funds is free government-side diligence on which dual-use technologies the buyers actually want.

The thick middle: 2024 to 2026 financings

The anchor exits are history. The live question is what is funding now. In 2025 the mega-rounds were dominated by defense tech, dual-use AI, and energy infrastructure. X-Energy, the Rockville advanced-nuclear company, raised a $779 million Series C1 and a $700 million Series D across 2024 and 2025. Govini in Arlington hit unicorn status at a $1.25 billion valuation on a $150 million round for defense-acquisition AI. HawkEye 360 raised $150 million for geospatial analytics. Auterion, Electra.aero, Heven AeroTech, Parry Labs, Defcon AI, and Rune Technologies all raised meaningful defense and aerospace rounds. Emerald AI pulled in a $52.2 million seed for grid-reliability AI in October 2025.

Two things matter for an angel reading that list. First, the earlier-stage pattern is different from the mega-rounds. At seed and Series A the action is in govtech SaaS, cybersecurity tooling, and health IT, which is where individual checks actually fit. Second, the headline funding number is more concentrated than it looks. X-Energy alone accounted for roughly 26% of the DMV's 2025 total, so the thick middle is thinner than $5.4 billion suggests. National defense tech took in around $50 billion in venture funding in 2025 per PitchBook, and Northern Virginia sits at the center of that wave, but concentration risk is real and worth pricing in.

DMV outcomes are overwhelmingly acquisitions by strategics like IBM, Cisco, Google, and Blackstone rather than splashy IPOs, which changes how and when you see money back. Before you commit, it is worth understanding how angel investors actually get paid, from IPO lockups to acquisitions.

Who's deploying capital, and how to get in

The DMV is relationship-driven to a degree that surprises coastal investors. Cold outreach does not work. Capital moves through angel groups, accelerator demo days, and a handful of public programs, and the way in is to show up where founders and investors already meet.

Angel groups

The region has more than a dozen active groups. These are the ones worth knowing first:

• Blu Venture Investors (Vienna, VA) is the heavyweight on the cyber side, investing $500K to $1M per deal across cybersecurity, health IT, and B2B SaaS, with 60-plus portfolio companies and a member network of operators.
• New Dominion Angels invests pre-seed through Series A across Virginia, Maryland, and DC, typically co-investing with other regional groups.
• Dingman Center Angels at the University of Maryland funds early-stage companies with Maryland ties and is a clean entry point for biotech and enterprise deal flow in the 270 Corridor.
• Baltimore Angels backs seed and Series A companies in and around Baltimore, with a healthcare and digital-health track record tied to the Johns Hopkins ecosystem.
• HVP Angels, the angel network connected to Halcyon, is the region's impact-focused group, pooling investors into SPVs around climate, health, and equitytech.
• District Angels launched in 2024 as the DCTAV syndicate, investing through SPVs at pre-seed and seed with a $1,000 minimum check and a $300 membership. It is sector-agnostic, runs a venture fellowship for new investors, and welcomes members from outside the region.
• Citrine Angels is a DC group of women investing in women-founded companies, founded in 2008 and a member of the Angel Capital Association.
• K Street Capital is a 100-member DC angel network that has put roughly $10M into 70-plus startups at seed stage across fintech, climate, cyber, healthcare, and media, and it manages the city's DC Venture Capital Program.
• Robin Hood Ventures is based in Philadelphia but runs active deal flow across Maryland and Northern Virginia, with members making individual decisions after the group screens.
• The Agora Initiative operates under DCTAV as a community for DC-area female founders, running curated founder-and-funder dinners, office hours, and a $10,000 venture challenge reviewed by a panel of about 30 local investors. It connects founders to angels in its network rather than deploying a pooled fund, so treat it as the front door to the local investor community rather than a check-writing syndicate.

Several of these groups, District Angels and HVP among them, invest through SPVs, and any remote deal you join will almost certainly come wrapped in one. If that structure is new to you, read how SPVs and RUVs work, what you pay, and when each makes sense.

Accelerators with investor access

MACH37 in Herndon is the longest-running market-centric cybersecurity accelerator in the country, founded in 2013 by the Commonwealth of Virginia. It runs two 90-day cohorts a year of eight to ten companies, invests around $50K to $75K for 5% to 7%, and reports that 64% of graduates raise follow-on capital and 83% are still in business. Its twice-yearly Demo Days in Herndon are the single most active on-ramp into DMV cyber deals, and the program actively courts out-of-region investors. AWS and General Dynamics are platinum sponsors.

Halcyon in DC runs an 18-month social-impact fellowship across climate, health, and equitytech, with a residency stipend and a fully deployed $5M Fund I behind it. In 2025 it ran a DMV Climate Innovation cohort focused specifically on the region. Booz Allen Ventures, the corporate arm of Booz Allen Hamilton, tripled its commitment to $300 million in 2025 and invests seed through Series B in AI, cyber, defense, and deep tech, which makes its portfolio a useful co-investment signal. TandemNSI, founded by Jonathan Aberman, connects non-traditional founders to national-security buyers, and the new Virtus Innovation Center and National Innovation Quarter in Arlington are purpose-built hubs for defense and energy startups.

Govtech and cyber diligence asks different questions than consumer or generic SaaS diligence. If you are new to evaluating an early MACH37 company, run it through a practitioner's three-gate framework for vetting founders, market, and deal terms before you wire anything.

Public and institutional capital

Public money shapes the early-stage market here more than in most regions. The DC Venture Capital Program is a $26 million SSBCI fund, at least $52 million with the required private match, managed by K Street Capital and aimed at seed and early-stage DC companies. Maryland's TEDCO runs a seed fund and a proposal lab that pulled in more than $28 million in federal grants for Maryland startups across 2024 and 2025. Virginia's CIT GAP Funds match MACH37 graduates with up to $100K, and the BioMaryland Center awards capital directly to life-sciences startups. None of these write checks to you, but they tell you where non-dilutive validation is flowing, which is exactly the kind of signal that de-risks an early commercial round.

How to build a DMV portfolio as an outsider

You cannot parachute into the DMV with a wire transfer and expect deal flow. The deals that reach coastal angels come through a few specific channels: Blu Ventures syndication, HVP and District Angels SPVs, and Revolution's Rise of the Rest Seed Fund portfolio. The fastest credible on-ramp is to attend a MACH37 Demo Day as a visiting investor, because the program wants out-of-region capital and will treat you as a welcome guest rather than an intruder. From there, the move is to build relationships over one or two cycles before expecting warm introductions.

For a local angel, the entry points are more direct: MACH37 Demo Days, membership in New Dominion Angels or Dingman Center Angels, and AFCEA Northern Virginia events for anything defense-focused. The DMV rewards showing up in person, repeatedly, in the places where cleared founders and the investors who back them already gather.

If you cannot get to Herndon for a Demo Day, the practical alternative is to access DMV deals through an online platform. We compared six angel investing platforms on regulation, minimums, fees, and curation, which is the right starting point for building a regional position remotely.

Whatever the channel, the diligence discipline is the same. Treat a federal contract or FedRAMP authorization as a product-market-fit signal, not as the whole business. Ask whether the government beachhead opens a commercial market or traps the company in the appropriations cycle. Watch In-Q-Tel and Booz Allen Ventures as free signals on which dual-use technologies the eventual acquirers want. And size your position for a market where the exits are real but concentrated, and where a single mega-round can distort the headline numbers.

People and publications worth following

The DMV runs on a small number of connectors. Steve Case built AOL in Dulles and now runs Revolution from DC, including the Rise of the Rest Seed Fund that has backed startups in 100-plus cities. Ted Leonsis, his Revolution co-founder, invests across DMV companies and connects the region's sports, media, and tech worlds. Reggie Aggarwal built Cvent from nothing to a $4.6 billion exit and is the living proof of the enterprise-SaaS path out of Tysons. Mac Conwell runs RareBreed Ventures out of Maryland and is one of the clearest voices on early-stage deal flow outside the coastal hubs. Jonathan Aberman, who founded TandemNSI, sits at the intersection of national security, startups, and policy and knows nearly everyone in DC tech. John Backus, co-founder of New Atlantic Ventures, has been a founding voice of Northern Virginia venture for years.

For ongoing coverage, the essential sources are Technical.ly DC for funding rounds and people moves, Virginia Business for govcon and defense-tech exits, the Washington Business Journal for M&A and venture coverage, Washington Technology for the federal-contracting context that drives so much of the market, and BioHealth Innovation for the 270 Corridor biotech scene.

Common questions

Is the DC area a good place to angel invest?

Yes, with a clear thesis. The DMV is one of the few U.S. markets where federal proximity is a structural advantage, and it has produced consistent nine and ten-figure exits in cyber, govtech, and biotech, including Mandiant at $5.4 billion and Cvent at $4.6 billion. It rewards investors who understand its dual logic, federal contract first and then commercial expansion, and it punishes investors who treat it like a generic SaaS market. The 2025 total of $5.4 billion in venture funding is real, but it is concentrated, so the right approach is a disciplined thesis rather than broad exposure.

What is the difference between govtech and defense tech in the DMV?

Govtech companies build software for government agencies as customers, usually with commercially scalable products, and they cluster in DC proper: think policy analytics, data intelligence, and enterprise SaaS sold into federal buyers. Defense tech builds for the Pentagon, the intelligence community, and defense primes, and it concentrates in Northern Virginia: drones, dual-use AI, geospatial analytics, and cyber. Both rely on federal contracts as validation, but defense tech carries longer procurement cycles and tighter security requirements, while govtech tends to graduate into commercial enterprise markets faster.

Can I invest in DMV startups from outside the region?

Yes, though it takes intent. Remote angels typically access DMV deals through Blu Ventures syndication, HVP or District Angels SPVs, or Revolution's Rise of the Rest portfolio. Several local groups, District Angels among them, explicitly welcome out-of-region members. The most effective on-ramp is to attend a MACH37 Demo Day as a visiting investor, since the program actively seeks outside capital, and then to build relationships over a cycle or two before expecting warm deal flow. Online platforms are the practical fallback if you cannot attend in person.

How does In-Q-Tel work, and can individual angels co-invest?

In-Q-Tel is the CIA's strategic venture arm, based in Arlington, and it passed its 800th investment in 2025. It invests in AI, cyber, space, quantum, microelectronics, and life sciences to bring commercial technology to the intelligence community. Individual angels cannot co-invest, so it is not an access vehicle. Its real value to angels is as a signal: an In-Q-Tel investment has historically been a leading indicator of federal contract wins, and its portfolio companies are frequently acquired by Big Tech, so tracking what it funds is a form of free government-side diligence.

Is Maryland biotech a separate track from the Northern Virginia tech scene?

Yes. Maryland's 270 Corridor runs on a different validation source than NoVA's cyber and defense market. Instead of a federal contract, the de-risking signal is NIH or BARDA funding, an FDA pathway, or a research tie to Johns Hopkins, and the cluster sits in Montgomery County around Bethesda, Rockville, and Gaithersburg. The companies, Novavax, MacroGenics, and Emergent BioSolutions among them, look nothing like a cyber startup, but the underlying logic, federal proximity de-risking the early product, is the same. Maryland funding reached roughly $2.4 billion across 250-plus deals in 2025.

Written by Cheryl Kellond, founder of Play Money. Serial founder, MIT Sloan MBA, active angel investor. Not investment advice, consult a qualified professional for your specific situation. Last updated: June 2026.